HighVista Strategies LLC

Position in IMCR — Immunocore Holdings plc

CIK 1335325 BOSTON, MA

Position in IMCR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,371,123

-$398,591 QoQ

Shares Held

43,185

-26.4% QoQ

Ownership

0.084%

of shares outstanding

% of Portfolio

0.31%

of 13F equity value

Holder Rank

#68

of 136 holders

Holding Since

Sep 2022

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HighVista Strategies LLC holds $278,365,756 across 70 Biotechnology names. IMCR ranks #55 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	113,031	$15,062,511
2	RVMD	Revolution Medicines, Inc.	66,983	$12,544,576
3	DFTX	Definium Therapeutics, Inc.	242,884	$11,425,263
4	IMVT	Immunovant, Inc.	277,873	$10,706,446
5	PRAX	Praxis Precision Medicines, Inc.	30,210	$10,114,005
6	RLAY	Relay Therapeutics, Inc.	506,235	$9,471,656
7	PCVX	Vaxcyte, Inc.	149,739	$8,704,328
8	TNGX	Tango Therapeutics, Inc.	260,070	$8,129,788

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,371,123	43,185	-26.4%	Shares	Sole	2026-08-14
2026-03-31	$1,769,714	58,697	+77.9%	Shares	Sole	2026-05-15
2025-12-31	$1,145,360	32,998	-5.1%	Shares	Sole	2026-02-17
2024-03-31	$2,259,530	34,762	-16.5%	Shares	Sole	2024-05-15
2023-12-31	$2,843,956	41,627	+4.6%	Shares	Sole	2024-02-14
2023-09-30	$2,065,827	39,804	-9.7%	Shares	Sole	2023-11-14
2023-06-30	$2,643,876	44,094	+234.2%	Shares	Sole	2023-08-14
2023-03-31	$652,311	13,194	0.0%	Shares	Sole	2023-05-15
2022-12-31	$752,981	13,194	-20.5%	Shares	Sole	2023-02-14
2022-09-30	$778,640	16,588	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.